Cited by 374Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurological diseases and metabolism

The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis

Wong, A·1999·Human Molecular Genetics

Abstract

Expansions of an intronic GAA repeat reduce the expression of frataxin and cause Friedreich's ataxia (FRDA), an autosomal recessive neurodegenerative disease. Frataxin is a mitochondrial protein, and disruption of a frataxin homolog in yeast results in increased sensitivity to oxidant stress, increased mitochondrial iron and respiration deficiency. These previous data support the hypothesis that FRDA is a disease of mitochondrial oxidative stress, a hypothesis we have tested in cultured cells from FRDA patients. FRDA fibroblasts were hypersensitive to iron stress and significantly more sensitive to hydrogen peroxide than controls. The iron chelator deferoxamine rescued FRDA fibroblasts more than controls from oxidant-induced death, consistent with a role for iron in the differential kinetics of death; however, mean mitochondrial iron content in FRDA fibroblasts was increased by only 40%. Treatment of cells with the intracellular Ca2+chelator BAPTA-AM rescued both FRDA fibroblasts and controls from oxidant-induced death. Treatment with apoptosis inhibitors rescued FRDA but not control fibroblasts from oxidant stress, and staurosporine-induced caspase 3 activity was higher in FRDA fibroblasts, consistent with the possibility that an apoptotic step upstream of caspase 3 is activated in FRDA fibroblasts. These results demonstrate that FRDA fibroblasts are sensitive to oxidant stress, and may be a useful model in which to elucidate the FRDA mechanism and therapeutic strategies.

Integrity signals

Registry

Crossref · 10.1093/hmg/8.3.425

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chemicals used to model PD, such as MPTP, 6-OHDA, and rotenone, increase expression of key members of the signaling pathway associated with the UPR in ER stress.

    “It may be noted that chemicals used to model PD, such as MPTP, 6-hydroxydopamine (6-OHDA), and rotenone, were shown to increase expression of key members of the signaling pathway associated with the UPR in ER stress (136, 327).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wong, A.
Affiliations
University of California, Davis (US)
Corresponding author
Wong, A
Venue
Human Molecular Genetics
Published
1999-03-01
Volume
8
Issue
3
Pages
425-430
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2145136975
Cited by
374
References
26
Citations by year
2026: 2 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 14 · 2018: 12 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 19 · 2013: 20 · 2012: 11
FWCI
8.43
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (AG-11967, R01AG011967)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
Friedreich's ataxia, frataxin, GAA repeat expansion, intronic repeat expansion, mitochondrial oxidative stress, oxidative stress, hydrogen peroxide sensitivity, iron chelation, deferoxamine, calcium chelation, BAPTA-AM, apoptosis, caspase-3, mitochondrial iron, fibroblasts, neurodegeneration
MeSH terms
Frataxin, Base Sequence, Calcium, Cell Line, Chelating Agents, Deferoxamine, Egtazic Acid, Fibroblasts, Friedreich Ataxia, Humans, Hydrogen Peroxide, Iron, Mutation, RNA, Messenger, Uridine, Case-Control Studies, Apoptosis, Phosphotransferases (Alcohol Group Acceptor), DNA Primers, Oxidative Stress, Pyruvic Acid, Caspases, Iron-Binding Proteins, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review